Skincare devices are getting more popular — showing growth in the past year — and their owners are reporting satisfaction, according to a new NPD Group survey.
StarWellness+ empowers pharmacies that wish to streamline their workflow for patients enrolled in medication synchronization.
HDMA’s board of directors re-elected its chairman and vice chairman while adding four new members with extensive knowledge of the healthcare supply chain.
Aurobindo’s latest generic is of Pfizer’s Lopid, which treats high cholesterol alongside diet and exercise.
The Risk Evaliation and Mitigation strategy training for libido drug Addyi is now available for prescribers and pharmacists, Sprout Pharmaceuticals said.
Mallinckrodt expects the $1.3 billion, all-cash deal to be accretive by about $0.10 per share on its diluted FY2016 earnings and increasingly accretive in subsequent years.
As a result of the $8.05 billion acquisition, Endo has adjusted its guidance for FY2015.
Dr. Reddy's is the latest company to introduce a generic version of AstraZeneca’s Nexium capsules.
Under the terms of the consent decree, the company will not be allowed to manufacture or sell dietary supplement products until the FDA has determined that the business is in compliance.
PhRMA's next leader hails from the Advanced Medical Technology Association, where he was president and CEO for more than 10 years.